info@seagull-health.com
SeagullHealth
语言:
search

Factors Affecting the Price of Dacomitinib

VIZIMPRO is supplied in 15 mg, 30 mg, and 45 mg tablets in 30-count bottles.

Availability and Storage

The tablets are available in three strengths and are packaged in child-resistant bottles. They should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted within 15°C to 30°C (59°F to 86°F).

Dacomitinib(Vizimpro)
Dacomitinib(Vizimpro)
​A kinase inhibitor indicated for the first-line treatment of metastatic...
WeChat Scan
Free Inquiry
Related articles
How to Buy Dacomitinib at a Lower Cost
Dacomitinib, with the English name Dacomitinib, is originally developed by Pfizer Inc. of the United States. It is a highly effective drug for the treatment of metastatic non-small cell lung cancer (N...
What is the Price of Dacomitinib?
Dacomitinib is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that has demonstrated significant efficacy in the treatment of EGFR mutation-positive...
What Are the Purchase Channels for Dacomitinib?
Dacomitinib is a second-generation EGFR tyrosine kinase inhibitor, which has been approved in China for the first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). The drug ...
What Are the Purchasing Channels for Dacomitinib?
Dacomitinib, also known by other names such as Vizimpro, Dacoplice, is mainly used for the treatment of metastatic non-small cell lung cancer (NSCLC) with positive epidermal growth factor receptor (EG...
How to Purchase Dacomitinib
The original developer of Dacomitinib (Vizimpro) is Pfizer Inc. of the United States. It is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, widely ...
What is the 2025 Latest Price of Dacomitinib?
Dacomitinib, a second-generation EGFR tyrosine kinase inhibitor developed by Pfizer, is mainly used for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. As a key drug in target...
共 13 条
  • 1
  • 2
  • 3
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved